medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2019, Number 12

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (12)

Contraceptive method of choice post-abortion

Valverde-Espinoza N, Barja-Ore J

Language: Spanish
References: 15
Page: 814-819
PDF size: 212.27 Kb.


ABSTRACT

Objective: Identify the contraceptive method chosen by the patients treated at a Hospital in Lima, Peru, after an abortion.
Materials and Methods:An observational, descriptive, retrospective and cross-sectional study was carried out at the San Bartolomé Hospital, in Lima, Peru, in 2017; women who had a diagnosis of abortion with favorable evolution and who received specialized counseling in the different contraceptive methods were included, regardless of whether they used a previous one; while those that had a serious complication were excluded. The choice of contraceptive methods in post-abortion was studied and the selection of women was made through a simple random probabilistic sampling. For the data analysis, the estimation of absolute and relative frequencies was performed.
Results: 116 women were included. 28.4% opted for a contraceptive method, and of these, 6.9% decided on a monthly injection, 6.9% for a quarterly injection, 6% for combined oral, 0.9% for a subdermal implant, 1.7% for an intrauterine device and 0.9% for tubal ligation. On the other hand, 59.5% of the observed women were not using a contraceptive method, in addition, 62.9% had at least one previous abortion and 31.4% had an abortion with their last pregnancy.
Conclusions: In this study sample, it was appreciated that the majority of women who aborted for some reason did not choose a contraceptive method; however, monthly and quarterly injectables were the most chosen among those who did choose one.


REFERENCES

  1. Schwarcz R, Fescina R, Duverges C. Obstetricia. 6a ed. Argentina: El Ateneo. 2008.

  2. Organización Mundial de la Salud. Prevención del aborto peligroso. [en línea] 2018. Dirección URL: (Consulta: abril del 2019)

  3. Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84(3):230- 233. DOI: https://doi.org /10.1016/j.contraception. 2011.01.013

  4. Ohannessian A, Jamin C. Contraception après interruption volontaire de grossesse. J Gynecol Obstet Biol Reprod. 2016;45(10):1568-1576. DOI: 10.1016/j.jgyn.2016.09.017

  5. Faúndes A, Zaidi S. Prevention of unsafe abortion: Analysis of the current situation and the task ahead. Int J Gynecol Obstet. 2010;110(Suppl 1):S38-S42. DOI: 10.1016/j. ijgo.2010.04.009.

  6. Borges A. Post-abortion contraception:effects of contraception services and reproductive intention. Cad. Saúde Pública. 2016;32(2):e00102015. DOI: http://dx.doi. org/10.1590/0102-311X00102015

  7. Morgan-Ortiz F, Muñoz-Acosta J, Valdez-Quevedo R, Quevedo-Castro E, Báez-Barraza J. Efecto del intervalo intergenésico postaborto en los resultados obstétricos y perinatales. Ginecol Obstet Mex. 2010;78(1):46-52. Dirección URL:

  8. Vilela A, Luciria R, Komura L, Fujimori E, Boorges C, Alves O. Anticoncepción postaborto: atención y prácticas. Rev Latino-Am Enfermagem. 2014;22(82):293-300. DOI: 10.1590/0104-1169.3240.2415

  9. Morgan-Ortiz F, Muñoz-Acosta J, Valdez-Quevedo R, Quevedo-Castro E, Báez-Barraza J. Efecto del intervalo intergenésico postaborto en los resultados obstétricos y perinatales. Ginecol Obstet Mex. 2010;78(1):46-52. Dirección URL:

  10. Huber D, Curtis C, Irani L, Pappa S, Arrington L. Postabortion Care: 20 Years of Strong Evidence on Emergency Treatment, Family Planning, and Other Programming Components. Rev Global health, sciencia and practice. 2016;4(3):481-494. DOI: https://doi.org/10.9745/GHSP-D-16-00052

  11. Ministerio de Salud. Norma técnica de salud de planificación familiar. Perú, 2017. Dirección URL:

  12. Banerjee S, Gulati S, Andersen K, Acre V, Warvadekar J, Navin D. Associations Between Abortion Services and Acceptance of Postabortion Contraception in Six Indian States. Stud Fam Plann. 2015;46(4):387–403. DOI: 10.1111/j.1728-4465.2015.00039.x

  13. Lira-Plascencia J, Velázquez-Ramírez N, Ibargüengoitia- Ochoa F, Montoya-Romero JJ, Castelazo-Morales E, Valerio- Castro E. Anticonceptivos de larga duración reversibles: una estrategia eficaz para la reducción de los embarazos no planeados. Ginecol Obstet Mex. 2013;81:530-540. Dirección URL:

  14. Ganatra B, Faundes A. Role of birth spacing, family planning services, safe abortionservices and post-abortion care in reducing maternal mortality. Best Pract Res Clin Obstet Gynaecol. 2016;36:145-155. DOI: 10.1016/j.bpobgyn. 2016.07.008.

  15. Keefe-Oates B, Makleff S, Sa E, Forero LJ, Mendoza D, Olaya MA, et al. Experiences with abortion counselling in Mexico City and Colombia: addressing women's fears and concerns. Cult Health Sex. 2019; 25:1-16. DOI: 10.1080/13691058.2019.1604995.




2020     |     www.medigraphic.com